Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
A group of inherited ectodermal dysplasias whose most prominent clinical feature is hypertrophic nail dystrophy resulting in PACHYONYCHIA. Several specific subtypes of pachyonychia congenita have been associated with mutations in genes that encode KERATINS.
Entry Term(s)
Congenital Pachyonychia
Jackson-Lawler Syndrome (Pc-2)
Jackson-Lawler Type Pachyonychia Congenita
Jadassohn-Lewandowski Syndrome (Pc-1)
Jadassohn-Lewandowsky Syndrome
Pachyonychia Congenita Jackson Lawler Type
Pachyonychia Congenita Syndrome
Pachyonychia Congenita Tarda, Type 1
Pachyonychia Congenita Type 1
Pachyonychia Congenita, Jackson-Lawler Type
Pachyonychia Congenita, Jadassohn-Lewandowsky Type
A group of inherited ectodermal dysplasias whose most prominent clinical feature is hypertrophic nail dystrophy resulting in PACHYONYCHIA. Several specific subtypes of pachyonychia congenita have been associated with mutations in genes that encode KERATINS.